Oct. 2, 2015:
Learn about the latest in insulin-based therapy at OMED 2015 during "Hitting the Target in Type 2 Diabetes: Evolving Approaches to Insulin-Based Therapy." Repeated sessions will be held Saturday, Oct. 17; Sunday, Oct. 18; and Monday, Oct. 19, in the West D Lobby next to registration in the Orange County Convention Center.
This CME-accredited Interacitve Professor program features pre-recorded expert faculty discussing the latest approaches to insulin-based therapy for Type 2 diabetes mellitus.
Using case studies and audience feedback at key clinical decision points, each 30-minute educaitonal session will:
Examine best practices for identifying patient-centered glycemic targets.
Compare the clinical profiles of current and emerging basal insulin analogs, including combination formulations.
Discuss tailoring insulin-based regimens to maximize multidimensional benefits and minimize treatment-related risks.
This activity is supported by an educational grant from Novo Nordisk, Inc.